Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coronavirus Update: Pfizer CEO Thinks Vaccine Price Rise Likely Post-Pandemic

Plus: SinoVac Results Disappoint, AstraZeneca Files in EU

Executive Summary

Companies will raise their COVID-19 vaccine prices once the pandemic is over – but key long-term data will determine which comes out on top.

You may also be interested in...



J.P. Morgan Day 1: Companies Make Deal-Making, COVID-19 Promises

Daily round-up from the virtual J.P. Morgan Healthcare Conference: Business development is key topic for Amgen and Vertex; BioNTech talks COVID-19 vaccine supply while Merck KGAA's new CEO pledges to rise to meet the challenges posed by COVID-19.

UK Begins Controversial 12 Week Strategy With AZ and Pfizer Vaccines

Entering a new lockdown, the UK sees its plans to space out doses of the COVID-19 vaccines to 12 weeks as crucial to overcoming the pandemic.

China Grants Conditional Approval To CNBG COVID Vaccine

State-owned China National Biotec Group becomes the first to get the greenlight for its inactivated virus-based vaccine to prevent COVID-19.

Topics

Related Companies

UsernamePublicRestriction

Register

SC143621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel